From €6175EUR$6,500USD£5,312GBP
- Report
- February 2024
- 150 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 150 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
North America
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
Europe
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
United States
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 80 Pages
Europe
From €4513EUR$4,750USD£3,882GBP
- Report
- August 2023
- 150 Pages
North America
From €4513EUR$4,750USD£3,882GBP
- Report
- August 2023
- 70 Pages
Middle East, Africa
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2021
- 500 Pages
United States
From €1938EUR$2,040USD£1,667GBP
€2280EUR$2,400USD£1,961GBP
- Report
- February 2024
- 70 Pages
South Africa
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
Indonesia
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
India
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
Japan
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 70 Pages
Italy
From €4513EUR$4,750USD£3,882GBP
Nesina is a brand of Endocrine and Metabolic Disorders Drugs, which are used to treat conditions such as diabetes, obesity, and hyperlipidemia. These drugs are designed to help regulate hormones and metabolism, and can be used to help manage blood sugar levels, reduce cholesterol, and promote weight loss. Nesina is a combination of two drugs, alogliptin and pioglitazone, which work together to help control blood sugar levels. It is available in tablet form and is taken once daily.
Nesina is manufactured by Takeda Pharmaceuticals, and is available in the United States, Canada, and Europe. Other companies that produce Endocrine and Metabolic Disorders Drugs include Novo Nordisk, Sanofi, and Merck. Show Less Read more